Fig. 2

Association of clinical features with tumor recurrence in low and high liver fibrosis. a Predicted nomogram scores of risks for 2- or 5-year recurrence was compared. Both cccDNA per hepatocyte (b) and HBV replicative activity (c) were compared between groups with and without tumor recurrence in patients of different liver fibrosis stages in non-neoplastic liver and tumor tissues. Wilcoxon rank sum test P value was used to measure the significance of the difference. Significant associations (P < 0.05) with tumor recurrence were marked in red color